Simcere Pharmaceutical Group said its in-house long-acting antagonist monoclonal antibody SIM0725, targeting the IL-2 receptor beta chain (CD122), has been approved by the National Medical Products Administration to begin clinical trials in China for autoimmune disease indications.

On the 10th the Houthi movement said it conducted four rounds of military operations. The first round struck Riyadh’s King Khalid International Airport and multiple pump stations along the east‑west oil pipeline, causing fires and damage to facilities. The second round targeted an ARAMCO facility at Abqaiq and, the group said, achieved its objectives. The third round hit Saudi forces deployed in the Mudariba and Ras Ala areas under officer Badr Halabi, inflicting heavy casualties; the fourth targeted Riyadh’s financial district. The group urged investors and companies to withdraw investments from Saudi Arabia and move capital to peaceful, secure countries, and denied Saudi claims the attack hit a Medina pipeline, saying the strike was on a Riyadh pipeline.

Canadian Foreign Minister Anand said Canada will reimpose sanctions on parties involved in the Iranian regime’s proliferation-sensitive nuclear activities.